Navigation Links


Promising at Biology News

Another Look Finds Promising Proteomics Test is Not Biologically Plausible

In a new study, researchers present a “cautionary tale?about what may go wrong when using the fledgling science of proteomics to devise a diagnostic test for cancer. In the February 16 issue of the Journal of the National Cancer Institute, researchers from The University of Texas M. D. Anderson Cancer Center detail why an experimental test intended to identify early ovarian cancer from a...

Gene vaccine for Alzheimer's disease shows promising results

UT Southwestern Medical Center at Dallasresearchers have found a way of stimulating the immune systems of miceto fight against amyloid proteins that cause the devastating plaquesthat are characteristic of Alzheimer's disease.For years scientists have examined the possibility of using aprotein-based vaccine to slow the progression of the disease in itsearly stages. UT Southwestern researcher...

Gene therapy promising for growing tooth-supporting bone

A University of Michigan research team has found that introducing a growth factor protein into a mouth wound using gene therapy helped generate bone around dental implants, according to a new paper in the February issue of the journal Molecular Therapy. In a patient with a sizeable mouth wound, replacing a tooth takes more than simply implanting a new one---the patient also needs the bone...

Promising new West Nile therapy cures disease in mice

West Nile virus alarmed Americans when it made its first U.S. appearance in New York City in 1999. It has since spread from coast to coast, sickened more than 16,000 Americans and killed more than 600. As the virus spread, medical investigators hastened research to develop an effective vaccine or therapy. None currently exist, but a newly published paper by researchers at Washington University in...

Silence the gene, save the cell: RNA interference as promising therapy for ALS

Scientists at the Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland have used RNA interference in transgenic mice to silence a mutated gene that causes inherited cases of amytrophic lateral sclerosis (ALS), substantially delaying both the onset and the progression rate of the fatal motor neuron disease. Their results will be published in the April issue of Nature Medicine, and in the...

More>>

Promising at Biology Products
Promising at Biology Technology

Wisconsins promising bio-refining future wont run on ethanol alone

President Bushs declaration that America is "addicted to oil" was paired with a pitch to produce more alcohol fuel, such as ethanol, in the nations grain belt. Its unclear whether Wisconsin can overcome a late start to become a leading ethanol producer, but the broader idea of using genetically engineered plants to create fuel, fiber, plastics and chemicals may be a...

UW-M engineering dean heads for promising medical business

Gregory, who is stepping down as dean of UW-M's College of Engineering and Applied Science in June, will retain his job as a tenured professor; but more important, he is looking forward to makin...
Promising at Medicine News

PCR emerging as a promising technique for Diagnosing Urinary Tuberculosis

Urinary Tuberculosis is often difficult to diagnose and many a times the diagnosis is made by exclusion. Urine polymerase chain reaction (PCR) is emerging as a promising technique for early diagnosis of Urinary Tuberculosis. The technique involves detection of bacteria by facilitating rapid amplification of small amounts of a genome sequence, Dr Narmada P Gupta told the Millennium International...

Experimental treatment for Ebola Virus Shows promising results in mice

Scientists at the Center for Disease Control and Prevention (CDC) in Atlanta, Georgia, have said that an experimental treatment for the deadly Ebola virus has shown promising results in mice. In the study, researchers led by Dr. Manish Gupta took antibodies from the immune systems of mice that had survived infection with the deadly Ebola virus and injected them into other Ebola-free mice...

A promising treatment for wart removal

Depending upon the body's own ability to get rid of warts, a researchers at the University of Arkansas for Medical Sciences are analysing and testing the needs. In a previous trial, they showed how a single injection got rid of warts in 70 per cent of participants.// The new treatment is a form of immunotherapy - that is, it stimulates the body to fight and destroy warts using its own defences....

Hepatitis shots is promising

Researchers observe that an experimental new combination of drugs for Hepatitis -C Cures more patients with fewer side effects than the standard treatment for the potentially deadly,liver destroying infection.// The new Treatment could give doctors a more potent weapon against the virus at a time experts are forecasting a surge in cases of Hepatitis- C liver damage over the next few yea...

Promising Treatment for Diabetes

Researchers appear to be on the road to a new and possibly better treatment for type 2 diabetes.// Doctors typically treat type 2 diabetics with oral medications to control blood sugar. They’ll sometimes also use insulin if the condition worsens. These medications are effective, but they also carry increased risk for low blood sugar, or hypoglycemia, particularly as people age. This st...

More>>

Promising at Medicine Products
Promising at Medicine Technology

BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease

WAKEFIELD, Mass.--(BUSINESS WIRE)--Jul 10, 2007 - BusinessWeekpublished an article on July 6 discussing the race bypharmaceutical and biotechnology companies to be first to bring tomarket an effective angiogenesis treatment for cardiovasculardisease. While angiogenesis therapies are being pursued bySanofi-Aventis, Boston Scientific, Baxter, and Genzyme, amongothers, the article highlights a...

BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease

WAKEFIELD, Mass.--(BUSINESS WIRE)--Jul 6, 2007 - BusinessWeek todaypublished an article discussing the race by pharmaceutical andbiotechnology companies to be first to bring to market an effectiveangiogenesis treatment for cardiovascular disease. Whileangiogenesis therapies are being pursued by Sanofi-Aventis, BostonScientific, Baxter, and Genzyme, among others, the articlehighlights a very...

Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop

PRINCETON, N.J.--(BUSINESS WIRE)--Jun 28, 2007 - CytogenCorporation (NASDAQ: CYTO) reported updated data from a Phase 1dose escalation study evaluating QUADRAMET(R) (samarium Sm-153lexidronam injection) in combination with bortezomib (Velcade(R),Millennium Pharmaceuticals, Inc.) in patients with relapsedmultiple myeloma. Data from 33 patients were presented today in aposter titled, "Phase 1...

CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS

LOS ANGELES--(BUSINESS WIRE)--Jun 27, 2007 - CytRx Corporation(NASDAQ:CYTR), a biopharmaceutical company engaged in thedevelopment and commercialization of human therapeutics, todayannounced promising data from the six-month, open-label extensionof its completed Phase IIa clinical trial with arimoclomol in ALSvolunteers. While the clinical trial was not placebo-controlled,arimoclomol at a 1...

Antisense Pharma: Promising Phase IIb Results of Targeted Therapy with AP 12009 in Recurrent Anaplastic Astrocytoma

CHICAGO and REGENSBURG - June 21, 2007 - “In anaplasticastrocytoma, AP 12009 as a monotherapy is actually clearly superiorto temozolomide,” Prof. Albert Wong, M.D., StanfordUniversity, California, U.S.A. commented on the international PhaseIIb study with the TGF-beta 2-inhibitor AP 12009, under developmentby Antisense Pharma. Prof. Wong discussed the results of the studyin th...

More>>

Other TagsCytoCytoCytoCytoCytoCytoCytoCytoStylette
(Date:7/25/2008)...ON, July 25 /PRNewswire/ -- The Elekta Family of C... treatment solutions at the 2008,American Associat...g,demonstrating how the joint forces of Elekta, I... therapy planning and delivery solutions that,stre...perience for,patients, as well as enhance clinicia...
(Date:7/25/2008)...ds fluid back-up in esophagus can cause immune sys...ay News) -- The first evidence linking gastroesoph...scovered by Duke University Medical Center researc...ns was first noted in the 1970s, and since then st...rcent of asthma patients also experience GERD symp...
(Date:7/25/2008)... The Retina Group of New York will...ted macular degeneration especially designed for s...e Public Library at 116 Merritts Road, Farmingdale.... Attendance is free and refreshments will be prov...6) 939-6100. , Hicksville...
(Date:7/25/2008)... This donation will be used to fac...ve services for children , ... ( www.ivci.com ), a leading integrator of enterp...tion video conferencing, telepresence, audio visua...announced today that it has donated video conferen...
Breaking Medicine News(10 mins):Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:People With GERD More Likely to Develop Asthma 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2
(Date:7/24/2008)...le typhoon in Taiwan buries as much carbon in the ...er rains in that country all year long combined. ... study published in a recent issue of the journal ...ine the chemistry of stream water and sediments th...s happening at full force -- will help scientists ...
(Date:7/23/2008)...ure into a domestic renewable fuel source could ge...cent of North America,s entire consumption needs a...as emissions (GHGs), according to US research publ...f Physics, Environmental Research Letters . , T...ions Benefits of Converting Manure to Biogas, has...
(Date:7/23/2008)...nations willing to collectively spend about $1 bil...y half a billion metric tons of carbon dioxide per.... , It would take about that much money to put ... the world, one of the top contributors to greenho...opted, this type of program could have potential t...
(Date:7/23/2008)...ll bring together internationally renowned scienti... China, Japan, Australia and India to address anc... , "We are bringing together the world,s best ...mit organizer J. William Schopf, founder and direc...ary Physics, Center for the Study of Evolution and...
Breaking Biology News(10 mins):Study: Typhoons bury tons of carbon in the oceans 2Study: Typhoons bury tons of carbon in the oceans 3Study: Typhoons bury tons of carbon in the oceans 4Cow power could generate electricity for millions 2Paying to save tropical forests could be a way to reduce global carbon emissions 2Paying to save tropical forests could be a way to reduce global carbon emissions 3Paying to save tropical forests could be a way to reduce global carbon emissions 4UCLA 'world summit' to explore ancient life on Earth, and beyond 2BioStorage Technologies Appoints Dr Wolfgang Hoffer as Managing Director of European Operations 3509 1BioStorage Technologies Appoints Dr Wolfgang Hoffer as Managing Director of European Operations 3509 2Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital 3507 1Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital 3507 2Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 12690 1Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 12690 2Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 12690 3Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 12690 4Pharsight Welcomes Newest Japanese PKS AutoPilot Customer 3505 1Pharsight Welcomes Newest Japanese PKS AutoPilot Customer 3505 2Pharsight Welcomes Newest Japanese PKS AutoPilot Customer 3505 3Pharsight Welcomes Newest Japanese PKS AutoPilot Customer 3505 4Pharsight Welcomes Newest Japanese PKS AutoPilot Customer 3505 5
Other Contentshemochromatosishemolysishemoglobinuriacrisiscrisiscrisiscrisishemophiliahemophiliahemophiliahemophiliahemophiliahemoptysishemorrhoid